DBL Pharmaceuticals entered into an agreement to acquire Cream and Ointment Manufacturing Line of GlaxoSmithKline Bangladesh Limited (DSE:GLAXOSMITH) on December 22, 2019. Under the terms, quality control equipment have also been acquired. The transaction is subject to approval by Directorate General of Drug Administration.